P3BEP
01 Dec 2020
ANZUP 1302
NCT02582697
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
University of Sydney
Cancer Type | Other |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 11-45 years |
Sex | Male |
Tumour Stream | Germ cell |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2014-02-01 |
Anticipated End Date | 2023-07-01 |
Hospital | Ashford Cancer Centre Research |
---|---|
Clinical Trial Coordinator | Sue Yeend |
syeend@adelaidecancercentre.com.au | |
Phone | 08 8292 2240 |
Principal Investigator | Professor Hsing Tan |
Recruitment Status | Recruitment on Hold |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | - |
Recruitment Status | Recruiting |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Hsiang Tan |
Recruitment Status | Recruiting |